Fibrinolytic activity of venous blood of patients with multiple sclerosis.
D000293:Adolescent; D000328:Adult; D000738:Androsterone / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002087:Butyrates / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood* / Q000188:drug therapy; D010919:Placebos; D013927:Thrombosis / Q000517:prevention & control; D014680:Veins
D000924:Anticholesteremic Agents; D002087:Butyrates; D000960:Hypolipidemic Agents; D010919:Placebos; D002784:Cholesterol; D000738:Androsterone